Concepts, components & configurations
Deferred consent: Use in clinical resuscitation research

https://doi.org/10.1016/S0196-0644(05)81703-2Get rights and content

Deferred consent, a new approach to the requirement for informed consent in clinical research, was used in a randomized clinical trial of brain resuscitation after cardiac arrest. Because patients were comatose and therapy had to be initiated immediately, traditional prospective consent usually could not be obtained. Using the deferred consent mechanism, family members were contacted after the first dose of experimental drug or placebo was administered and asked to consent for continued study participation. The vast majority of families were satisfied with the deferred consent mechanism. Their main concerns were about the safety of the experimental drug and whether the active drug or placebo was given. The concepts of randomization, blinding, and placebo-treated controls were generally not well understood. Although our experiences confirmed the impracticality of attempting to obtain traditional prospective consent in clinical resuscitation research, deferred consent was found to be a reasonable solution.

References (9)

  • AbramsonN et al.

    Lidoflazine administration to survivors of cardiac arrest

    Ann Emerg Med

    (1989)
  • Protection of Human Subjects, 45 CFR Pt 46, Subpt...
  • AbramsonNS et al.

    Informed consent in resuscitation research

    JAMA

    (1981)
  • AbramsonNS et al.

    Deferred consent: A new approach for resusciation research

    JAMA

    (1986)
There are more references available in the full text version of this article.

Cited by (48)

  • Long-term neurological outcomes in patients after out-of-hospital cardiac arrest

    2016, Resuscitation
    Citation Excerpt :

    The date of patient's death was obtained from the National Health Insurance Service in South Korea. Neurologic status was classified according to the CPC,7,14,15 a scale that included five categories. CPC 1 was defined as conscious and alert with good cerebral performance; CPC 2 as conscious and alert with moderate cerebral performance; CPC 3 as conscious with severe cerebral disability; CPC 4 as comatose or in a persistent vegetative state; and CPC 5 as brain dead or dead by traditional criteria.

  • Ethical and regulatory considerations in the design of traumatic brain injury clinical studies

    2015, Handbook of Clinical Neurology
    Citation Excerpt :

    Even when family members are available, it is often difficult for them to make a thoughtful decision regarding research while also dealing with a sudden and unexpected traumatic event (Schats et al., 2003). To address this issue, the concept of deferred consent was used in the 1980s for resuscitation research (Brain Resuscitation Clinical Trial I Study Group, 1986; Abramson and Safar, 1990). Deferred consent made it possible to contact the family after the first dose of an experimental drug or placebo had been administered and later request consent to continue participation in the study (Abramson and Safar, 1990).

  • Ethical challenges and solutions regarding delirium studies in palliative care

    2014, Journal of Pain and Symptom Management
    Citation Excerpt :

    Ultimately, the participant must make a decision, and the person obtaining consent, therefore, must have formulated an impression as to this individual's capacity, regardless of who else was additionally consulted. Deferred consent is used in emergency research and refers to the consent obtained after the treatment or intervention has commenced and when the patient has regained capacity or a proxy is engaged (deferred proxy).70,71 Delirium is clearly an acute condition that can be part of a terminal process, especially in PC settings, so this could be considered an appropriate solution.

  • Ethical considerations in neuroemergency clinical trials

    2006, Handbook of Neuroemergency Clinical Trials
View all citing articles on Scopus

This study was supported by NIH Grant No. NS15295.

19 hospital worldwide of the BRCT II Study Group. The BRCT II Study Group

View full text